52

Bharat Immunologicals and Biologicals Corporation LtdBOM 524663 Stock Report

Last reporting period 31 Mar, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.01

Micro

Exchange

XBOM - Bombay Stock Exchange

524663.BO Stock Analysis

52

Uncovered

Bharat Immunologicals and Biologicals Corporation Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.01

Dividend yield

Shares outstanding

43.18 B

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. The company operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

View Section: Eyestock Rating